$ 1.38
Key Takeaways
Risk factor
Very high price volatility
Profitability factor
Very low or no dividends
About
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It offers medical and adult-use cannabis products, including GMP-certified flowers,...
Company Valuation
From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks.
Target Price
The average target price of TLRY is 1.0 and suggests 25% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to decr
